13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000225602
Total reported value
$2.4B
$2.4B
2 檔
62.3%
During the Q1 2025 filing period, Massachusetts Mutual Life Insurance Co (CIK: 0000225602) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.4B across 2 reported positions.
In Q1 2025, Massachusetts Mutual Life Insurance Co adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 46 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVZ | Invesco Ltd. | Stock-Financials | 83.19% | -0.92% | — | |
| 2 | JEF | Jefferies Financial Group In | Stock-Financials | 16.81% | +0.92% | — |
According to official SEC Form 13F filings, Massachusetts Mutual Life Insurance Co reported a total U.S. public equity portfolio value of $2.4B across 2 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IVZ, JEF) accounted for 62.3% of total reported equity market value during Q1 2025.
Top New Position Initiated
IVZ
市值: $1.2B
Top Position Liquidated / Trimmed
OEF
前期市值: $6.7M
During Q1 2025, Massachusetts Mutual Life Insurance Co's top holdings by market value included IVZ (83.2%)、JEF (16.8%). The largest single position, IVZ, represented 83.2% of total portfolio value.
In Q1 2025, Massachusetts Mutual Life Insurance Co made 48 total portfolio adjustments, initiating 2 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 46 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.